Top 30 Biotech Startup Investors in Taiwan (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Darwin Venture Management
VC Fund
|
4 | Taiwan, United States, Japan | Seed, Series A | Software, Manufacturing, Information Technology | $350k–$76M |
|
WI Harper Group
VC Fund
|
3 | United States, Taiwan, China | Series A, Seed, Series B | Software, Health Care, Biotechnology | $1.1M–$41M |
|
Translink Capital
VC Fund
|
3 | United States, China, South Korea | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $4M–$55M |
|
Verge HealthTech Fund
VC Fund
|
2 | Estonia, Singapore, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical Device, Medical | $500k–$4.6M |
|
National Development Fund of Taiwan Government
VC Fund
|
2 | Taiwan, United States, China | Seed, Series A, Series B | Software, Information Technology, Health Care | $400k–$30M |
|
China Development Industrial Bank (CDIB)
VC Fund
|
2 | United States, Taiwan, China | Series B, Series A | Biotechnology, Health Care, Medical | $2.8M–$51M |
|
AVA Angels
VC Fund
|
2 | Taiwan, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $330k–$10M |
|
Maxpro Ventures
VC Fund
|
2 | Taiwan | Series A, Venture - Series Unknown | Biotechnology, Retail, Medical | |
|
Fubon Financial Holdings
VC Fund
|
2 | Taiwan, United States, Israel | Series A, Series B | Biotechnology, Software, Medical | $5M–$27M |
|
NCTU Angel Club
VC Fund
|
2 | Taiwan, United States | Seed, Series A | Medical, Health Care, Biotechnology | $750k–$5M |
|
TaiAn Technologies
VC Fund
|
1 | Taiwan, United States | Series A, Series B | Biotechnology, Medical, Therapeutics | $13M–$23M |
|
Taiwania Capital Management Corporation
VC Fund
|
1 | United States, Taiwan, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Biotechnology | $3M–$85M |
|
BE Healthcare Ventures
VC Fund
|
1 | Taiwan, Thailand | Seed, Series A, Series B | Health Care, Medical, Software | |
|
Lippo Group
VC Fund
|
1 | United States, Singapore, China | Seed, Series A | Internet, E-Commerce, FinTech | $3.5M–$4.8M |
|
Biomark Capital
VC Fund
|
1 | Taiwan, United States | Series A, Series E | Health Care, Biotechnology, Medical | |
|
TMI Holding Corp.
VC Fund
|
1 | Taiwan, United States | Series D | Life Science, Consumer, Software | |
|
Bill Chang
Angel
|
1 | Taiwan | Series A | Genetics, Software, Health Care | |
|
DCI Partners
VC Fund
|
1 | Japan, Taiwan, United States | Series B, Series A | Biotechnology, Health Care, Product Research | $7.1M–$553M |
|
Pangu Venture Capital
VC Fund
|
1 | China, Taiwan, United States | Series A, Seed, Angel | Biotechnology, Apps, SaaS | $12M–$27M |
|
Taiwan Surface Mounting Technology
VC Fund
|
1 | Taiwan | Seed | Medical, Health Care, Biotechnology | |
|
Alibaba Entrepreneurs Fund
VC Fund
|
1 | Hong Kong, Taiwan, United States | Series A, Seed, Series B | Software, E-Commerce, Artificial Intelligence | $510k–$150M |
|
VENTURE+
VC Fund
|
1 | Taiwan | Series A, Seed | SaaS, Software, Rental | |
|
Taya Venture Capital
VC Fund
|
1 | United States | Series A | Life Science, Biotechnology, Health Diagnostics | |
|
Center Ventures
VC Fund
|
1 | China | Series B | Medical, Biopharma, Health Care | |
|
CDIB Capital
VC Fund
|
1 | China, Taiwan, United States | Series B, Series A, Series C | Health Care, Biotechnology, Information Technology | $1.5M–$100M |
|
John Hsuan
Angel
|
1 | Taiwan | Series A, Series B | Medical, Health Care, Biotechnology | |
|
Might Electronic
VC Fund
|
1 | Taiwan | Seed | Medical, Health Care, Biotechnology | |
|
Alzheimer's Drug Discovery Foundation
VC Fund
|
1 | United States, Canada, Spain | Grant, Series A | Biotechnology, Health Care, Health Diagnostics | |
|
Integrated Capital
VC Fund
|
1 | India, Taiwan, Croatia | Series A, Seed, Series B | E-Commerce, Food and Beverage, Automotive | |
|
Mega International Commercial Bank
VC Fund
|
1 | Taiwan, Philippines | Series A, Debt Financing | Banking, Payments, Biotechnology | $158M–$500M |
| Access all 30 investors in Taiwan Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Taiwan, United States, Japan
Investor stats
- Total investments: 124
- Round size: Seed $350k–$43M; Series A $3M–$76M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- BitBiome — BitBiome is a microbiome analysis company that aims to discover and understand disease-linked microorganisms. Its, single-cell whole-genome analysis platform specifically targets microbes and can be used on uncultured, raw samples, providing unprecedented strain-level quantitative and functional insights.THe company was founded in 2018 and isbased in Japan.
- Instalimb — Instalimb is the world's first 3D printing prosthesis business.
- Findy — Findy is a Japanese company once surprised the world by sending out products such as cars and home appliances one after another
We take a diversified approach, investing in the early stage, across multiple sectors with our deep domain expertise.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Taiwan, China
Investor stats
- Total investments: 148
- Round size: Seed $1.1M–$5M; Series A $2M–$15M; Series B $6M–$41M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $174M in 2016
Portfolio highlights
- DivX — Download free DivX Software to play, convert and cast video including DivX, AVI, MKV and HEVC files up to 4K. Play AVI and convert to MP4!
- Ultriva — Ultriva is a lean manufacturing software that enables you to adapt quickly and deliver impressive results. Experience modern lean manufacturing now. Learn more.
- Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
Translink Capital is a trailblazing Silicon Valley VC with unmatched institutional connections to Asia's economic powerhouses.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, China, South Korea
Investor stats
- Total investments: 160
- Round size: Series A $4M–$27M; Series B $9.8M–$42M; Series C $10M–$55M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Appier — Comprehensive AI-Powered Solutions: Smoother Operaions. Elevated Customer Experience. Better Performance.
- Eclypsium — Eclypsium's platform enhances supply chain security by incorporating zero-trust in every device, fortifying hardware, firmware, and software.
- Plus One Robotics — The fastest and most reliable parcel handing robotics solutions in your warehouse.
We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging AsiaWe believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Estonia, Singapore, United Kingdom
Investor stats
- Total investments: 24
- Round size: Seed $500k–$4.6M; Pre-Seed $500k–$1M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $17k in 2021
Portfolio highlights
- Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
- Lifeyear — Digital-first heart care. At scale.
- CareLoop Health — CareLoop, an innovation emerging from the University of Manchester, furnishes patients with digital support resources while simultaneously providing healthcare professionals with the means to monitor and track patient symptoms.
The national development fund is the management unit of the non-business cycle budget fund, which is tasked with grouping. It aims to accelerate the industrial innovation value-added, promote economic transformation and national development, and help china's industrial innovation value-added, research and development and self-owned brands. Thefinancing method or assisting the competent authorities of the central government to handle the relevant plans to complete the purposes specified in article 30 of the "industry innovation ordinance".
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Taiwan, United States, China
Investor stats
- Total investments: 40
- Round size: Seed $400k–$7M; Series A $2M–$15M; Series B $10M–$30M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- MedicalTek — MedicalTek (MDTK) is located in Taichung, Taiwan. We specialize in developing and manufacturing in MonoStereo 3D endoscopic imaging system that using in MIS surgery.
- H2U — Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products.
- Numbers Protocol — Explore Numbers Protocol, a leader in blockchain-driven digital media authenticity aligned with C2PA standards. Join our robust platform to secure and verify digital content through advanced blockchain technology.
CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan's industrial development, CDIB has built up a wealth of experience in high-tech investment while its investment overseas has extended to the US,Japan, Korea and S.E. Asia.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Taiwan, China
Investor stats
- Total investments: 62
- Round size: Series A $2.8M–$34M; Series B $20M–$51M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Eden Biologics — Eden Biologics, formerly known as JHL Biotech ("JHL") , is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development tocommercial manufacturing with both global and regional regulatory affairs expertise.
- AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
AVA Angels is an angel group which focus on connecting angel stage to venture stage of startups. AVA Angels has brought together many outstanding angel investors to find and evaluate together high-quality investment targets, to quickly establish the startup ecosystem and the startup investors network.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Taiwan, United States, Hong Kong
Investor stats
- Total investments: 39
- Round size: Seed $330k–$5M; Pre-Seed $350k–$2.5M; Series A $3.9M–$10M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Zeabur — A platform that help you deploy your service with one click, No matter what programming language you use, what framework you use.
- Pet 100% — Pet 100% is a pet store that offers grooming services, nutritional supplements, deworming for pets, and protective services for animals.
- AlleyPin — AlleyPin Interactive helps SMBs grow their businesses by elevating their online presence and bringing more customers to their doorsteps. These great results are achieved through our proprietary marketing solutions making it easy for customers of the SMBs to leave great online reviews.
Maxpro Ventures is an investment firm focused on breakthrough biomedical technology companies. We identify and invest in such excellent companies worldwide with our private equity and venture capital expertise.
Show more...Investment focus
- Industry: Biotechnology, Retail, Medical
- Stage:Series A, Venture - Series Unknown
- Geography: Taiwan
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
- StellarCell.Bio — StellarCell.Bio is a regenerative medicine company focused on the research, development, and implementation of cell therapy technologies.
- Full Chain Materials International — Full Chain Materials is a Retail company focused on supplying and sourcing a broad range of chemicals and equipment to customers.
Fubon Financial Holdings has built a strong lineup of financial service companies. Its major subsidiaries include Fubon Life, Taipei Fubon Bank, Fubon Bank (Hong Kong), Fubon Bank (China), Fubon Insurance, Fubon Securities, and Fubon Asset Management. Fubon Financial Holdings had total assets of US$283.9 billion as of the end of 2019, rankingsecond among Taiwan’s financial holding companies, and it has been the most profitable company in the industry in terms of earnings per share (EPS) for eleven consecutive years. The company was also named to the Fortune Global 500 for the second consecutive year in 2019.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Series A, Series B
- Geography: Taiwan, United States, Israel
Investor stats
- Total investments: 11
- Round size: Series A $5M–$27M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
- AnnJi Pharmaceutical — AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). Thefocus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs.
- Tetanti Agribiotech Inc. — Dr. Young holds a PhD degree in agronomy and soil science awarded by University of Hawaii. He is the pioneer in the field of organic fertilizer and soil microorganisms in Taiwan and was awarded the Academician honor in 2016.TTT® technology is the world’s only destructive and innovative concept that revolutionizes the traditional microbialcomposting process with the use of enzymes to stabilize and mature organic wastes. It raises the maturing efficiency more than 100-fold, and our zero pollution composting technology is able to avoid bad smell and waste water produced during the process.Dr. Young has profound influence on the industry in Taiwan and will lead our business to expand internationally as well as establish our group at the top of circular economy.•Broad microorganism and enzyme database:We possess more than 7,000 bacterial isolates that can provide functional and optimized enzyme formulations for different composting materials. •Professional know-how service:The rapid composting technology is a combination of microbiology, biochemistry, soil science, physics, as well as long term practical experiences. It can provide all-around total solution services for any organic wastes. •No more NIMBY protests:Rapid composting technology is pollution-free and can resolve the protests from the neighborhood.
NCTU Angel Club is an angel investment group that encourages an aspiring young person to start a business.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: Taiwan, United States
Investor stats
- Total investments: 5
- Round size: Seed $2.4M–$3M; Series A $750k–$5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MoBagel — MoBagel’s vision is to bring AI-driven decision making to enterprises through software and services. MoBagel has empowered global enterprises to extract business insights and create value from their data across industries including retail, telecom, manufacturing, banking, and more.
- Hukui Bio — Founded in November 2013, HuKui Bio provides total solution and value-added services to global medical devices customers. By focusing on medical electronics and handheld devices for digital healthcare and telemedicine, we do the designing and development in Taiwan, manufacturing in Asia, and delivering our sales & services globally. Combiningseasoned experts and investors from biomedical, tech, and financial industries, we strive to be the best partner in the Asia-Pacific region for MedTech developers, startups and corporates by completing projects on-time, on-budget and by meeting global quality standards concurrently. Our US company, HuKui Tech, is a subsidiary based in the Bay area, 100% owned by HuKui Bio since 2020.
- Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!TaiAn Technologies Corporation is a technology advisory company that specializes in commercializing intellectual properties in the life sciences. Our team comprised of numerous biomedical experts that work closely with investment professionals to support up-and-coming life science technologies. Most importantly, we are entrusted by our shareholdersto explore technology platforms in the life sciences arena, to build upon the novel technologies, and to transform them into viable business opportunities supporting existing or creating new entities. Our shareholders comprised of Development Fund of the Executive Yuan of Taiwan as well as numerous conglomerates that are recognized in Taiwan and internationally well known. Leveraging our shareholders/ partners' resources and our strong management team, our multiplex services create synergies with Taiwanese corporations and add significant value to your company.
Show more...Investment focus
- Industry: Biotechnology, Medical, Therapeutics
- Stage:Series A, Series B
- Geography: Taiwan, United States
Investor stats
- Total investments: 3
- Round size: Series A $13M–$23M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
- APRINOIA Therapeutics — APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Its goal is to create novel products to meet critical patient needs,including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
- Sapience Therapeutics — Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme(GBM), which is the most severe and deadly form of brain cancer.The company was founded in 2015 by Barry Kappel and is based in Scarsdale, New York, United States.
NEWS Nurturing Stalwarts of Future Industries Taiwan us [...]
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Taiwan, United Kingdom
Investor stats
- Total investments: 79
- Round size: Seed $3M–$11M; Series A $4.9M–$85M; Series B $10M–$55M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Opsera — Opsera automates any CI/CD toolchain, enables declarative pipelines, and provides unified insights across your entire software delivery process.
- Viracta Therapeutics — Our team possesses deep, cross-functional experience and shares a longstanding commitment to developing new medicines to benefit cancer patients. Management Strategic Advisor Board of Directors Scientific Advisory Board
- Regenacy Pharmaceuticals — Regenacy Pharmaceuticals is a pioneer in developing novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme ("HDAC") inhibitors.
BE Health Ventures is a boutique advisory and investment company, specializing in technologies, financials and healthcare industries.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Series B
- Geography: Taiwan, Thailand
Investor stats
- Total investments: 7
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- AIM — AIM focuses on affordable and easy access to early preventive detection, precision diagnosis and automated prognosis monitoring of prevailing chronic diseases at vast installations of points-of-care.
- Meticuly — Meticuly is a global leader in 3D printed patient specific implant. We use cutting-edge technology to create precise, customized implants for improved patient care. Visit to learn more!
- H2U — Health to U is a provider of digital health and wellbeing platform, focusing on holistic health, sports, and diets. The H2U Digital Health platform is a breakthrough creation, a framework that maximizes the power of data. The service delivers insightful reviews based on the platform’s analyses of data collected from connected products and services,elevating the overall value of each component. Users are able to get their hands on their records anytime at will, allowing them to stay aware and on top of their physiological states, with access to personalized health solutions and products.
PT Lippo Karawaci Tbk ("Lippo Karawaci") was founded on a vision to impact lives through the development of well-planned sustainable independent townships within green environments and first class physical and social infrastructure. Over more than a decade, the Company has proven itself to be a highly trusted property developer with amost recognisable brand name. It is the owner of the largest diversified landbank and a leader in pioneering projects in strategic locations throughout Indonesia. Through a merger of 8 property related companies in 2004 the Company has expanded its business portfolio to encompass urban development, large scale integrated developments, retail malls, healthcare, hotels and leisure, as well as a fee-based income portfolio.Lippo Karawaci is now the largest listed property company in Indonesia by market capitalisation, assets and revenue, with a unique and integrated business model. It operates Indonesia’s premier private hospital group, the only one achieving world class standards, and is an undisputed retail property industry leader.
Show more...Investment focus
- Industry: Internet, E-Commerce, FinTech
- Stage:Seed, Series A
- Geography: United States, Singapore, China
Investor stats
- Total investments: 9
- Round size: Seed $3.5M–$4.8M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Tencent — Tencent is an internet service portal offering value-added internet, mobile, telecom, and online advertising services. Its communications and social platforms Weixin and QQ connect users with each other, with digital content and daily life services in just a few clicks. Tencent has maintained steady growth under its user-oriented operatingstrategies. It provides value-added internet, mobile, and telecom services, as well as online advertising under the strategic goal of providing users with "one-stop online lifestyle services." Tencent’s Internet platforms in China – QQ (QQ Instant Messenger), WeChat, QQ.com, QQ Games, Qzone, 3g.QQ.com, SoSo, PaiPai, and Tenpay – aim to address the various needs of internet users, including communication, information, entertainment, e-commerce, and others.In September 2013, Tencent's market valuation rose to $101 billion, and as of November 21, 2013, QQ had 2 billion active users and WeChat had 650 million monthly active users. The numbers of active users for QQ mail, Qzone, Tencent Weibo, and QQ news were 274 million, 626 million, 220 million, and 150 million, respectively.Tencent was founded in November of 1998. In April 2000, the IDG and PCCW invested a total of $2.2 million dollars in the company. Tencent was listed on the Hong Kong Stock Exchange (SEHK) on June 16, 2004. Baidu, Alibaba, and Netease are Tencent's major competitors.
- Fairbanc — Fairbanc is a scalable, AI-powered mobile loan and payments platform for emerging market small-medium enterprises (SMEs) that requires no collateral or credit history.The company's AI-powered platform can read digital footprints such as transaction history with large suppliers, and data on the mobile phone to grant instant digital creditline that SMEs can use to purchase inventories from our selected suppliers. Fairbanc's proven gender-intelligent ecosystem for loans and payments can be used in many vertical markets, eliminating the shortcomings of cash. Retail shop-owners can boost sales up to 20%, eliminate cash shortages, enjoy an easier payments regimen, and develop a credit history; suppliers receive more consistent order cycles, more instant payments upon delivery, and SKU sales expansion.
- MoolahGo — The leading MAS-licensed payment platform purpose-built for Asian businesses. Pay, collect and manage in 40+ currencies including every major ASEAN market.
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies tocollaborate with them in accelerating growth and building successful business ventures.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series E
- Geography: Taiwan, United States
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- i2Dx —
- Eden Biologics — Eden Biologics, formerly known as JHL Biotech ("JHL") , is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development tocommercial manufacturing with both global and regional regulatory affairs expertise.
- WhiteGlove Health —
TMI Holding Corp. is a Taipei-based, institutionalized angel investment firm that funds internet and mobile startups.
Show more...Investment focus
- Industry: Life Science, Consumer, Software
- Stage:Series D
- Geography: Taiwan, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SmartAnalyst — Putnam is a trusted consulting partner that bridges the highest levels of scientific and strategic excellence for global life science companies.
- R+W Studios — R+W is a global agency & startup incubator based in Hong Kong, Taipei, New York and Washington DC.
Bill Chang
Show more...Investment focus
- Industry: Genetics, Software, Health Care
- Stage:Series A
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ATGENOMIX — ATGENOMIX is a specialist next generation sequencing and enterprise-grade complete Bio-IT platform for accelerating genomic data processing with accuracy, scalability and reliability.
DCI Partners is a venture capital firm specializing in the fields of drug discovery and regenerative medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Product Research
- Stage:Series B, Series A
- Geography: Japan, Taiwan, United States
Investor stats
- Total investments: 17
- Round size: Series A $21M–$105M; Series B $7.1M–$553M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Luxna Biotech — Luxana Biotech is established to contribute to medical treatment for suffering patients, .
- Scohia Pharma — Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic.
- Surv Biopharma — Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.
Pangu Venture Capital a venture capital firm specializing in the Internet, life sciences, cleantech, artificial intelligence, and culture
Show more...Investment focus
- Industry: Biotechnology, Apps, SaaS
- Stage:Series A, Seed, Angel
- Geography: China, Taiwan, United States
Investor stats
- Total investments: 6
- Round size: Series A $12M–$27M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- AutoBrain — AutoBrain focuses on the research and development of advanced and intelligent automatic driving systems.
- No. 1 workplace — No.1 workplace is a workplace service platform. It helps companies and candidates to achieve job matching through AI technology.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Taiwan Surface Mounting Technology assembles printed circuit boards.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Hong Kong, Taiwan, United States
Investor stats
- Total investments: 68
- Round size: Seed $510k–$7M; Series A $2M–$68M; Series B $7M–$150M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $130M in 2015
Portfolio highlights
- PanopticAI — PanopticAI is a health system that uses artificial intelligence and signal processing to comprehend the human body and improve health.
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
VENTURE+ is the next generation venture capital bringing founders not only MONEY but also STRATEGIC VALUES. The company invests in early-stage companies and helps them with growth strategy and critical resources. With solid track records and hands-on experiences, VENTURE+ often plays a co-founding partner role providing more doing than talking. Weare thrilled and good at helping startups make an impact on the world.
Show more...Investment focus
- Industry: SaaS, Software, Rental
- Stage:Series A, Seed
- Geography: Taiwan
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- NUEIP — NUEIP focuses on creating smart databases, data visualization, and customized charts to enhance business operations efficiency.
- 25sprout — 25sprout is a digital creative consultancy that provides website development, SaaS, business automation, software and app design.
- Yifang Life — Yifang Life offers services related to rental renovations, leasing, and management, including a tenant management rental plan for tenants.
Taya Venture Capital Co., Ltd. is a subsidiary of Daya Wire & Cable Group and has focused on discovering and investing in industries with growth potential. The company owns several professional investment funds, including Taya Ventures , Taya Innovation , Taya Genesis, and other NT dollar funds, as well as Taya Venture, a US dollar fund .
Show more...Investment focus
- Industry: Life Science, Biotechnology, Health Diagnostics
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
- Apeximmune Therapeutics — Apeximmune Therapeutics is pioneering a new generation of therapeutic antibodies and biologics that harness the power of the immune system to deliver curative treatments for cancer and autoimmune disease.
Founded as a pharmaceutical company, they are equipped with practical experience and business expertise in biotechnology. Their familiarity with the industry value chain and ecosystem, along with complete expert network and resource integration capabilities, make us the most professional biotechnology incubator platform in Asia Pacific.
Show more...Investment focus
- Industry: Medical, Biopharma, Health Care
- Stage:Series B
- Geography: China
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Hipot — Hipot is a technological innovation company dedicated to providing hydrogen fuel cell commercial vehicle transportation solutions.
- Immunwork — Immunwork develops innovative drugs that combine targeting and effector functions to enhance efficacy and safety. The company focuses on creating ultralong-acting analogues, such as TE-8214, an octreotide derivative, and TE-8035, a modified human insulin. Immunwork's drug pipeline addresses immune system diseases and leverages a proprietarytechnology platform. The company is involved in clinical trials to validate its therapeutic solutions.
- Baoji Pharmaceutical — Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production.
CCIC CDIB International Corp.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Series B, Series A, Series C
- Geography: China, Taiwan, United States
Investor stats
- Total investments: 45
- Round size: Series A $1.5M–$16M; Series B $10M–$100M; Series C $4.3M–$40M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $405M in 2015
Portfolio highlights
- Redcliff — Redcliff is a drone management company that organizes aerial shows and events for private and public organizations.
- QT Medical — QT Medical’s technology empowers the patients to take an active role in managing their heart disease. Heart disease is responsible for 1 out of every 4 deaths in the U.S. and is the number 1 killer world-wide. No longer do patients with heart disease have to make long trips to their cardiologists, hospitals, or emergency rooms to get diagnostic,hospital-grade ECG scans. They can now perform these tests from the comfort of their homes or anywhere with an internet connection, allowing peace of mind, saving time, reducing stress, and improving outcomes.
- Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
John Hsuan
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Taiwan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hukui Bio — Founded in November 2013, HuKui Bio provides total solution and value-added services to global medical devices customers. By focusing on medical electronics and handheld devices for digital healthcare and telemedicine, we do the designing and development in Taiwan, manufacturing in Asia, and delivering our sales & services globally. Combiningseasoned experts and investors from biomedical, tech, and financial industries, we strive to be the best partner in the Asia-Pacific region for MedTech developers, startups and corporates by completing projects on-time, on-budget and by meeting global quality standards concurrently. Our US company, HuKui Tech, is a subsidiary based in the Bay area, 100% owned by HuKui Bio since 2020.
Matt Electronics provides one-stop services from product development, design verification, small-scale trial production, mass production to international logistics.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Iweecare — Founded in Taiwan Taipei 2014, iWEECARE is collaborating with electronics manufacturers and TSMT (Taiwan Surface Mounting Technology) to create the best user friendly product- Temp Pal® All their team members are parents and expecting couples, who have experienced the morning hassle of checking BBT (Basic Body Temperature) chart and sleeplessnights worrying about child fever. That’s why they put their engineering and medical expertise to developing Temp Pal®, a device designed to make temperature monitoring easier and more comfortable.
The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions andbiopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Health Diagnostics
- Stage:Grant, Series A
- Geography: United States, Canada, Spain
Investor stats
- Total investments: 49
- Lead/follow: no public data
Portfolio highlights
- Modulo Bio — Modulo is decoding the neuroimmune system. Applying science and engineering to identify new treatment paths for neurodegenerative diseases.
- Alamar Biosciences — Alamar Biosciences is a proteomics company redefining the limits of Protein Biomarker Detection with unrivaled precision. Learn more about what we offer here.
- University of Gothenburg — University of Gothenburg is a school in Gothenburg.
Integrated Capital is a multi strategy investment firm investing across private and public equity, private credit and special situations.
Show more...Investment focus
- Industry: E-Commerce, Food and Beverage, Automotive
- Stage:Series A, Seed, Series B
- Geography: India, Taiwan, Croatia
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- Entri — India's leading vernacular learning platform for Job Seekers. Learn Coding, Digital Marketing, Commerce, Spoken English and more.
- The Naked Market — The Naked Market
- Surglasses — Surglasses specializes in providing cutting-edge augmented reality surgery systems, specifically designed for orthopedics and neurosurgery. These systems offer precise surgical assistance and enhance surgical success rates, improving medical quality and patient safety.
Mega International Commercial Bank is a result of the merger of International Commercial Bank of China and Chiao Tung Bank.
Show more...Investment focus
- Industry: Banking, Payments, Biotechnology
- Stage:Series A, Debt Financing
- Geography: Taiwan, Philippines
Investor stats
- Total investments: 3
- Round size: Debt Financing $158M–$500M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- China Bank — At China Bank, we are committed to making your success our business. We offer a complete range of deposit, investment, financing, remittance, and insurance products and services, accessible through our vast network of branches nationwide and secure and reliable electronic banking channels: China Bank TellerCard (ATM), China Bank Online (internet& mobile banking) and China Bank Tellerphone (phone banking)
- Sierra Gorda SCM — Sierra Gorda SCM is a low-grade mining company that focuses on producing copper and molybdenum concentrates.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Investors in Taiwan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 investors investing in Taiwan Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!